Suppr超能文献

[血清降钙素原对非脓毒症危重症患者病情严重程度的预后价值]

[The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].

作者信息

Ma Junyu, Wang Shupeng, Chen Desheng, Duan Jun, Li Chen, Li Gang

机构信息

Department of Surgery Intensive Care Unit, China-Japan Friendship Hospital, Beijing 100029, China. Corresponding author: Li Gang, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Aug;28(8):688-93. doi: 10.3760/cma.j.issn.2095-4352.2016.08.004.

Abstract

OBJECTIVE

To evaluate the correlation between serum procalcitonin (PCT) level and severity of diseases caused by different kinds of stress factors, and to identify the prognostic value of PCT on the prognosis in non-sepsis critically ill patients.

METHODS

A retrospective case control study was conducted. The clinical data of non-sepsis critically ill patients with age of ≥ 18 years admitted to surgery intensive care unit (ICU) of China-Japan Friendship Hospital from August 2013 to December 2015 and stayed for more than 3 days were enrolled. The PCT level in the first 24 hours, acute physiology and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score and 28-day mortality were recorded. Patients were divided into different groups by the original injury, including trauma stress group, stroke stress group and non-infection inflammation stress group. According to PCT level, patients were divided into PCT normal group, low level group, medium level group and high level group. Furthermore, patients were divided into survival group and non-survival group according to 28-day prognosis. The clinical data of patients were compared among the groups, and the correlations among different markers were analyzed with Pearson or Spearman correlation analysis. The predictive value of PCT on prognosis of non-sepsis critically ill patients was evaluated with receiver operating characteristic curve (ROC).

RESULTS

Ninety-four non-sepsis critical ill patients were enrolled, with 28 patients in trauma stress group, 30 in stroke stress group, and 36 in non-infection inflammation stress group, as well as 32 patients in PCT normal group, 18 in low level group, 18 in medium level group, and 26 in high level group. Of them, 78 survivors and 16 non-survivors were found. (1) The PCT level of non-sepsis critically ill patients was significantly positively correlated with APACHE II score and SOFA score (r1 = 0.688, r2 = 0.771, both P = 0.000). (2) The PCT level in trauma stress group was significantly higher than that in stroke stress group and non-infection inflammation stress group [μg/L: 4.43 (0.86, 11.72 ) vs. 0.28 (0.16, 5.85), 2.39 (0.13, 4.11), both P < 0.01]. APACHE II score (13.9±7.5, 13.9±7.0 vs. 9.4±4.4), SOFA score [7.0 (4.0, 9.0), 5.0 (3.0, 8.0) vs. 4.0 (2.0, 6.0)], and 28-day mortality [21.4% (6/28), 33.3% (10/30) vs. 0 (0/36)] in trauma stress group and stroke stress group were significantly higher than those of non-infection inflammation stress group (all P < 0.05). The abnormal rate of PCT in trauma stress group was significantly higher than that of stroke stress group and non-infection inflammation stress group [100.0% (28/28) vs. 33.3% (10/30), 66.7% (24/36), both P < 0.01]. (3) Non-survivors had significantly higher PCT level [μg/L: 6.02 (4.43, 18.34) vs. 0.76 (0.16, 4.11)], APACHE II score (22.5±3.8 vs. 10.1±5.1) and SOFA score [9.0 (7.0, 11.0) vs. 4.0 (2.0, 8.0)] as compared with those of survivors (all P < 0.01). (4) APACHE II score (7.8±2.8, 9.3±4.3, 13.7±6.2, 18.7±5.8, F = 22.495, P = 0.000), SOFA score [3.0 (1.2, 4.8), 4.0 (3.5, 4.5), 6.0 (3.5, 8.0), 10.0 (8.8, 12.0), Z = 51.040, P = 0.000], and 28-day mortality [0 (0/32), 11.1% (2/18), 22.2% (4/18), 38.5% (10/26), χ (2) = 15.816, P = 0.001] were gradually increased as PCT level elevated. (5) The area under ROC curve (AUC) of PCT for evaluating prognosis of non-sepsis critically ill patients was 0.799 [95% confidence interval (95%CI) = 0.709-0.889, P = 0.000], when the cut-off value was 4.2 μg/L, the sensitivity was 87.5%, and the specificity was 77.6%.

CONCLUSIONS

Serum PCT level was positively correlated with severity of illness in non-sepsis critically ill patients, which had predicted value on prognosis. Trauma stress can lead to higher PCT level than stroke stress and non-infection inflammation stress can.

摘要

目的

评估血清降钙素原(PCT)水平与不同应激因素所致疾病严重程度之间的相关性,并确定PCT对非脓毒症重症患者预后的预测价值。

方法

进行一项回顾性病例对照研究。纳入2013年8月至2015年12月在中国-日本友好医院外科重症监护病房(ICU)住院且年龄≥18岁、住院时间超过3天的非脓毒症重症患者的临床资料。记录患者入院后前24小时的PCT水平、急性生理与慢性健康状况评分系统II(APACHE II)评分、序贯器官衰竭评估(SOFA)评分及28天死亡率。根据原始损伤情况将患者分为不同组,包括创伤应激组、卒中应激组和非感染性炎症应激组。根据PCT水平将患者分为PCT正常组、低水平组、中等水平组和高水平组。此外,根据28天预后情况将患者分为生存组和非生存组。比较各组患者的临床资料,并采用Pearson或Spearman相关分析方法分析不同指标之间的相关性。采用受试者工作特征曲线(ROC)评估PCT对非脓毒症重症患者预后的预测价值。

结果

共纳入94例非脓毒症重症患者,其中创伤应激组28例,卒中应激组30例,非感染性炎症应激组36例;PCT正常组32例,低水平组18例,中等水平组18例,高水平组26例。其中,存活患者78例,死亡患者16例。(1)非脓毒症重症患者的PCT水平与APACHE II评分和SOFA评分呈显著正相关(r1 = 0.688,r2 = 0.771,P均 = 0.000)。(2)创伤应激组患者的PCT水平显著高于卒中应激组和非感染性炎症应激组[μg/L:4.43(0.86,11.72) vs. 0.28(0.16,5.85),2.39(0.13,4.11),P均<0.01]。创伤应激组和卒中应激组的APACHE II评分(13.9±7.5,13.9±7.0 vs. 9.4±4.4)、SOFA评分[7.0(4.0,9.0),5.0(3.0,8.0) vs. 4.0(2.0,6.0)]及28天死亡率[21.4%(6/28),33.3%(10/30) vs. 0(0/36)]均显著高于非感染性炎症应激组(P均<0.05)。创伤应激组PCT异常率显著高于卒中应激组和非感染性炎症应激组[100.0%(28/28) vs. 33.3%(10/30),66.7%(24/36),P均<0.01]。(3)与存活患者相比,死亡患者的PCT水平[μg/L:6.02(4.43,18.34) vs. 0.76(0.16,4.11)]、APACHE II评分(22.5±3.8 vs. 10.1±5.1)及SOFA评分[9.0(7.0,11.0) vs. 4.0(2.0,8.0)]均显著升高(P均<0.01)。(4)随着PCT水平升高,APACHE II评分(7.8±2.8,9.3±4.3,13.7±6.2,18.7±5.8,F = 22.495,P = 0.000)、SOFA评分[3.0(1.2,4.8),4.0(3.5,4.5),6.0(3.5,8.0),10.0(8.8,12.0),Z = 51.040,P = 0.000]及28天死亡率[0(0/32),11.1%(2/18),22.2%(4/18),38.5%(10/26),χ(2) = 15.816,P = 0.001]逐渐升高。(5)PCT评估非脓毒症重症患者预后的ROC曲线下面积(AUC)为0.799 [95%置信区间(95%CI) = 0.709 - 0.889,P = 0.000],当截断值为4.2 μg/L时,灵敏度为87.5%,特异度为77.6%。

结论

非脓毒症重症患者血清PCT水平与病情严重程度呈正相关,对预后具有预测价值。创伤应激比卒中应激和非感染性炎症应激更能导致更高的PCT水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验